Don M Bailey's Net Worth
$142 Million
Who is Don M Bailey?
Don M Bailey has an estimated net worth of $142 Million. This is based on reported shares across multiple companies, which include Lineage Cell Therapeutics, Inc., STAAR SURGICAL CO, Oncocyte Corp, Mallinckrodt plc, Asterias Biotherapeutics, Inc., COMARCO INC, and QUESTCOR PHARMACEUTICALS INC.
SEC CIK
Don M Bailey's CIK is 0001223697
Past Insider Trading and Trends
2011 was Don M Bailey's most active year for acquiring shares with 30 total transactions. Don M Bailey's most active month to acquire stocks was the month of July. 2014 was Don M Bailey's most active year for disposing of shares, totalling 48 transactions. Don M Bailey's most active month to dispose stocks was the month of February. 2008 saw Don M Bailey paying a total of $2,927,224.68 for 1,278,044 shares, this is the most they've acquired in one year. In 2014 Don M Bailey cashed out on 2,886,462 shares for a total of $78,892,934.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $1.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +153.49% | 96.16K |
$1.04 | $100,001.20 | 158.8K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19 - Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STAAR SURGICAL CO (STAA) Snapshot price: $29.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
| -26.46% | -39.20K |
$9.00 | -$450,000.00 | 108.94K |
May 13 - May 15
| |||
Form 4
| -33.75% | -50.00K |
$9.00 | -$450,000.00 | 98.14K |
May 13 - May 15
| |||
Form 4
| +2.07% | 3K |
—
|
—
| 148.14K |
May 14
| |||
Form 4
| +53.85% | 50.8K |
$5.53 | $280,747.47 | 145.14K |
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +40.77% | 44.87K |
—
|
—
| 154.94K |
Nov 14
| |||
Form 4
| +4.00% | 4.4K |
$2.97 | $13,048.00 | 114.47K |
Jun 3
| |||
Form 4/A
| +3.43% | 3.65K |
$2.87 | $10,465.00 | 110.06K |
Jun 2
| |||
Form 4
| -0.05% | -50.00 |
$2.87 | -$325.00 | 110.06K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| +37.74% | 26.41K |
—
|
—
| 96.42K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
| No matching records found | |||||||||
Oncocyte Corp (OCX) Snapshot price: $3.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.33% | -458.00 |
$55.69 | -$25,506.02 | 139.15K |
Mar 16
| |||
Form 4
|
—
|
0
|
$74.70 | -$4,910,345.16 | 139.61K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
$77.28 | -$4,026,282.80 | 139.61K |
Scheduled
|
Apr 13
| ||
Form 4
| +2.20% | 3K |
$131.21 | -$79,513.26 | 139.61K |
Mar 19
| |||
Form 4
|
—
|
0
|
$75.18 | -$3,858,142.00 | 136.6K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
$62.68 | -$3,521,307.77 | 136.6K |
Scheduled
|
Feb 13
| ||
Form 4/A
| +21.10% | 62.34K |
—
|
—
| 357.78K |
Aug 14
| |||
Form 4
| -74.86% | -221.18K |
$85.23 | -$18,850,915.71 | 74.27K |
Sep 8
| |||
Form 4/A
| -48.80% | -737.23K |
$70.40 | -$7,533,210.09 | 773.58K |
Aug 14 - Aug 15
| |||
Form 4
| +57.34% | 190.9K |
$71.66 | -$7,219,100.06 | 523.79K |
Aug 14 - Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Asterias Biotherapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
∞
| 88.23K |
$3.39 | $299,116.65 | 88.23K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||